Posts tagged with "Galena Biopharma Inc (NASDAQ:GALE)"

Are These Stocks Worth Considering? First Horizon National Corp (FHN), Cobalt International Energy, Inc. (CIE) and Galena Biopharma Inc (GALE)

Posted by Saimoon May 20, 2015 0 Comment 2102 views

New York, NY – GDP INSIDER  –  05/20/2014. This article discusses three companies: First Horizon National Corp (NYSE:FHN), Cobalt International Energy, Inc. (NYSE:CIE) and Galena Biopharma Inc (NASDAQ:GALE) First Horizon National Corp (NYSE:FHN) continued its bullish run with the stock hitting a new all time high of $14.87 before falling back slightly to close up […]

Is It Worth Investing In Galena Biopharma Inc(NASDAQ:GALE), Sequenom, Inc.(NASDAQ:SQNM), and Tullow Oil Plc(UK)(OTCMKTS:TUWOY)?

Posted by Saimoon December 18, 2014 0 Comment 1305 views

New York, NY – GDP INSIDER  –  12/18/2014. This investment analysis article discusses Galena Biopharma Inc(NASDAQ:GALE), Sequenom, Inc.(NASDAQ:SQNM), and Tullow Oil Plc(UK)(OTCMKTS:TUWOY) Galena Biopharma Inc(NASDAQ:GALE) announced on December 11 that the preliminary immunohistochemistry (IHC) screening data from the NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT trial had been disclosed at the 2014 San Antonio Breast Cancer Symposium. […]

Galena Biopharma Inc (NASDAQ:GALE) Starts The New Year With A Bang

Posted by Beth Hart January 22, 2014 0 Comment 865 views

The New Year has come in with a bang for Galena Biopharma Inc (NASDAQ:GALE). The company has caught the eye of many investors in the healthcare business as the stock for the company has already seen a significant rise by about 40% in just three weeks. The share prices for the company have risen from […]

What Galena Biopharma Inc. (NASDAQ:GALE) Presented At SITC Conference?

Posted by George Brook November 13, 2013 0 Comment 2416 views

A pharmaceutical company engaged in the research and development of targeted oncology treatments, Galena Biopharma Inc. (NASDAQ:GALE) recently announced to have made a poster presentation at the SITC (Society for Immunotherapy of Cancer) Conference 2013 held at National Harbor, Maryland during November 7-10, 2013. The company presented findings of its Phase I trial related to […]

Did Galena Biopharma Inc (NASDAQ:GALE) Find Cure For Cancer Pain?

Posted by Michael Korte October 1, 2013 0 Comment 1300 views

Very recently, Galena Biopharma Inc (NASDAQ:GALE) assimilated approximately $37M from its share offering even as it prepares for the Abstral launch. For those who stepped in late, Abstral is a sublingual pill that is used as a breakthrough treatment for cancer pain. This drug had been originally developed by Orexo. In March, Galena Biopharma Inc […]

Galena Biopharma Inc (NASDAQ:GALE)’s stock rated as “outperform”, Ascent Solar Technologies, Inc. (NASDAQ:ASTI)

Posted by Kristi Scott May 29, 2013 0 Comment 9824 views

Hartford, CT 05/29/2013 (GDPInsider) – Galena Biopharma Inc (NASDAQ:GALE) shares closed at $2.51 per share, a fall of 1.95% (-$0.05) from its last closing price of $2.56. The stock had started this trading session at the opening price of $2.48 and has so far today seen a price ranging from a low of $2.42 to […]